Genomic Health Updates Investors on Timeline for DCIS, Colon Cancer, Prostate Cancer Tests

Keeping an eye on growing its global presence and test menu, Genomic Health does not plan to significantly grow its profits in future years, but will instead reinvest that money into research and development efforts.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.